Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. (2019) Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, et al. Journal article A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task. (2019) Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, et al. Journal article Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer. (2019) Welslau M, Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Ettl J, et al. Journal article, Review article [Correction: Use of Negative Pressure Wound Therapy with Instillation and Dwell Time for Wound Treatment - Results of an Expert Consensus Conference]. (2019) Horch RE, Braumann C, Dissemond J, Lehner B, Hirche C, Woeste G, Wozniak G, et al. Journal article, Erratum An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. (2019) Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, et al. Journal article Überlegungen zur Finanzierung von Simulationstrainings mit Crew Resource Manage-ment für die Patientensicherheit (2019) Schroeder S, Schöffski O Book chapter / Article in edited volumes Pet positivity after 2 cycles of abvd is a risk factor in patients with early-stage favorable Hodgkin lymphoma treated in the phase 3 GHSG HD16 study (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Hitz F, Greil R, Sasse S, et al. Conference contribution BRAF inhibitor treatment in hairy cell leukemia: a long-term follow up study (2019) Liebers N, Roider T, Bohn JP, Pircher A, Ferstl B, Ebnoether M, Perker M, et al. Conference contribution Expression of Prostate-specific Membrane Antigen (PSMA) in papillary renal cell carcinoma (pRCC) (2019) Zschaebitz S, Erlmeier F, Stoehr C, Polifka I, Schrader AJ, Hartmann A, Ivanyi P, Steffens S Conference contribution Eine große Chance im Arbeitsschutz für Beschäftigte im Freien verspielt (2019) Drexler H, Diepgen TL Journal article